KOSDAQ · Healthcare · ₩339B
₩25,300-0.59%
What's this stock's score right now?
See its score for free — revenue and money flow, graded on one standard.
Quarterly Financials
6/'26
3/'26 vs prev quarter
Short Volume 8.4% · as of 26.09.11
Among 15 신약 개발 peers
Quarterly Revenue Growth
“제조 기반은 넓어졌지만 실적 확인은 다음 단계예요.”
In the company's words · 2026 2분기 filing